Table 2.

Clinicopathologic characteristics of 19 patients evaluated for phosphorylated p70S6K

Gender, No. (%)
Male	15 (79)
Female	4 (21)
Age, years
Median (range)	64 (42–84)
Stage
Locally advanced	5 (26)
Recurrent or metastatic	14 (74)
Primary site, No. (%)
Oral cavity	8 (42)
Larynx	3 (16)
Oropharynx	4 (21)
Unknown primary	2 (11)
Other	2 (11)
Prior treatment, No. (%)
Surgery	15 (79)
Radiotherapy	14 (74)
Chemotherapy	14 (74)
None	4 (21)
Cetuximab treatment
Cetuximab alone	12 (63)
Cetuximab concurrently with radiotherapy	7 (37)